Phase III Randomized, Double-Blind, Placebo-Controlled Study of Antenatal Thyrotropin-Releasing Hormone in Pregnant Women With Threatened Premature Delivery

NCT00004778 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1090
Enrollment
NIH
Sponsor class

Conditions

Interventions

Sponsor

National Center for Research Resources (NCRR)

Collaborators